LEAP THERAPEUTICS INC - COM (LPTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2017 to Q2 2023

Type / Class
Equity / COM
Symbol
LPTX on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of LEAP THERAPEUTICS INC - COM (LPTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q2 0 $0 -$14,686,677 0
2023 Q1 43,213,381 $14,678,973 +$3,302,319 $0.34 56
2022 Q4 32,949,031 $14,827,364 -$4,282,992 $0.45 59
2022 Q3 37,118,700 $32,662,073 -$641,512 $0.88 66
2022 Q2 37,588,856 $43,231,309 -$8,691,212 $1.15 66
2022 Q1 43,242,620 $75,678,289 -$3,830,853 $1.75 78
2021 Q4 42,893,823 $138,979,388 -$9,037,932 $3.24 74
2021 Q3 41,873,407 $167,914,000 +$87,477,419 $4.01 62
2021 Q2 21,593,660 $35,401,968 -$2,158,081 $1.64 38
2021 Q1 22,636,072 $43,008,475 -$4,132,929 $1.90 44
2020 Q4 24,433,123 $54,974,536 -$3,097,138 $2.25 47
2020 Q3 24,887,852 $49,277,000 -$8,035,482 $1.98 37
2020 Q2 28,783,626 $59,907,000 +$36,697,409 $2.09 45
2020 Q1 11,230,428 $17,739,000 +$12,848,640 $1.58 20
2019 Q4 3,310,355 $3,706,000 -$584,168 $1.12 12
2019 Q3 3,774,131 $4,416,000 +$1,334,882 $1.17 17
2019 Q2 2,604,688 $4,661,000 +$895,146 $1.79 12
2019 Q1 2,103,544 $3,932,000 +$245,234 $1.87 10
2018 Q4 1,932,011 $3,863,000 -$3,028,969 $2.00 17
2018 Q3 2,281,180 $17,771,000 -$2,976,365 $7.79 23
2018 Q2 2,647,640 $23,829,000 +$1,712,650 $9.00 20
2018 Q1 2,469,039 $20,494,000 +$17,113,912 $8.30 19
2017 Q4 401,591 $2,508,000 +$1,762,168 $6.25 14
2017 Q3 121,135 $699,000 +$239,712 $5.78 7
2017 Q2 75,716 $496,000 -$45,226 $6.54 6
2017 Q1 82,497 $757,000 +$757,000 $9.18 5